Nutritional supplements and herbal medicine also play a role in integrative COPD management. Certain supplements, such as omega-3 fatty acids and antioxidants, have been associated with reduced inflammation and improved lung function. Herbal remedies like ginger and ginseng have demonstrated potential benefits in reducing respiratory symptoms and enhancing immune function.
Integrative approaches in Chronic Obstructive Pulmonary Disease (COPD) Treatment require collaboration between conventional healthcare providers and complementary therapists. Healthcare professionals need to be knowledgeable about the evidence and safety of complementary therapies to guide patients in making informed decisions. Open communication and shared decision-making between patients and their healthcare team are crucial for creating personalized treatment plans that incorporate complementary therapies.
Yoga and meditation promote relaxation, reduce stress, and enhance mindfulness, which can help individuals cope with the psychological and emotional impact of living with a chronic disease like COPD. However, it is important to consult with healthcare professionals before starting any supplements or herbal treatments, as they may interact with prescribed medications. Complementary therapies encompass a range of non-conventional approaches, including acupuncture, yoga, meditation, nutritional supplements, and herbal medicine. These therapies can be used alongside conventional treatments to alleviate symptoms, improve lung function, and promote overall well-being.
Read more @ https://influentialblogging.blogspot.com/2023/05/chronic-obstructive-pulmonary-disease.html
The Chronic Obstructive Pulmonary Disease (COPD) was valued at US $10.78 billion in the year 2018 and is estimated to reach US $14.27 billion by 2026, at a CAGR of 3.57%.Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory lung disease that causes airflow obstruction and breathing difficulties.
Further, COPD symptoms include frequent coughing, increased breathlessness, wheezing and tightness in the chest.The class of drugs for the treatment of COPD includes bronchodilators, leukotriene antagonists, mast cell stabilizers and immunosuppressants.
There were around 251 million cases of COPD reported globally by WHO.
Tobacco smoking is a major risk factor for COPD and approximately 20% of smokers develop the disease and about 15–20 % of COPD cases are due to occupational exposures to pollutants at the workplace.
However, due to a surge in the industrial activities in the Asian Pacific region, especially in China, India, Vietnam, Bangladesh, etc.
Increased automotive, industrial exhaust gases are degrading air quality and have led to the increased incidence of asthma due to immense pollution, especially in the low-income population in the emerging economies.
